These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22619349)

  • 1. Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.
    Wang X; Magkos F; Patterson BW; Reeds DN; Kampelman J; Mittendorfer B
    Eur J Endocrinol; 2012 Aug; 167(2):217-23. PubMed ID: 22619349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Magkos F; Patterson BW; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1243-9. PubMed ID: 16835398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDL-triglyceride secretion in overweight and obese men.
    Smith GI; Magkos F; Reeds DN; Okunade AL; Patterson BW; Mittendorfer B
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3454-62. PubMed ID: 23750033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.
    Magkos F; Fabbrini E; Patterson BW; Eagon JC; Klein S
    Metabolism; 2011 Nov; 60(11):1641-8. PubMed ID: 21632078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological interindividual variability in endogenous estradiol concentration does not influence adipose tissue and hepatic lipid kinetics in women.
    Magkos F; Fabbrini E; Patterson BW; Mittendorfer B; Klein S
    Eur J Endocrinol; 2022 Sep; 187(3):391-398. PubMed ID: 35895691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men.
    Magkos F; Patterson BW; Mohammed BS; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1568-74. PubMed ID: 17264219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics.
    Fabbrini E; Magkos F; Patterson BW; Mittendorfer B; Klein S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E414-8. PubMed ID: 22238397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity.
    Mittendorfer B; Patterson BW; Klein S
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E549-56. PubMed ID: 12475754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics.
    Magkos F; Patterson BW; Mittendorfer B
    J Lipid Res; 2007 May; 48(5):1204-11. PubMed ID: 17325388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women.
    Mittendorfer B; Yoshino M; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4151-4160. PubMed ID: 27588438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.
    Ooi EM; Watts GF; Chan DC; Chen MM; Nestel PJ; Sviridov D; Barrett PH
    Diabetes Care; 2008 Aug; 31(8):1656-61. PubMed ID: 18509206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.